查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1859891

冠状动脉绕道手术手术（CABG）：全球市场份额和排名、总销售额和需求预测（2025-2031 年）

Coronary Artery Bypass Grafts (CABG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 95 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球冠状动脉绕道手术手术 (CABG) 市场规模预计在 2024 年达到 1.42 亿美元，预计到 2031 年将达到 2.02 亿美元，在预测期（2025-2031 年）以 5.2% 的复合年增长率增长。

冠状动脉绕道术（CABG 手术），俗称心臟绕道手术或搭桥手术，是一种恢復阻塞的冠状动脉正常血流的外科手术。

冠状动脉绕道手术手术（CABG）是一种外科手术，它利用自体或人工血管在狭窄或阻塞的冠状动脉周围建立旁路通路，从而恢復心肌的血液供应。这可以保护心肌，缓解缺血症状，并降低不良心臟事件的风险。作为多支血管和复杂冠状动脉疾病的标准治疗方法，CABG涵盖了从传统的开胸体外循环到先进的微创技术以及辅助支持方法。手术全期生态系（包括移植血管的保存、术中灌注管理、止血、耗材和术后復健）构成了一个完整的市场，涵盖医疗设备、一次性耗材、药物辅助治疗和服务。

公共卫生领域对心血管疾病负担的持续关注，为冠状动脉绕道手术（CABG）领域提供了可持续的需求基础，因为持久的疗效和长期的生活品质至关重要。移植物保存、术中血液管理和替代移植物材料方面的创新，以及上市公司和研发公司不断扩大的商业化规模，正在拓展可供选择的产品类型类别，并为那些能够将临床证据与可扩展的生产能力相结合的公司创造了绝佳的商业机会。

关键阻碍因素包括严格的监管要求、对长期临床证据的需求以及严格的品管。新型器械和移植材料通常需要漫长的临床试验以及与监管机构的沟通，才能纳入标准手术流程。上市后的安全或品质问题可能会对合规成本和品牌信誉产生重大影响。供应链的稳健性、无菌生产能力以及医院预算动态也构成特定的商业化风险。

本报告旨在按地区/国家、类型和应用对全球冠状动脉绕道手术移植术 (CABG) 市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本文以收益为准，以 2024 年为基准年，对冠状动脉绕道手术移植术 (CABG) 的市场规模、估算和预测进行了阐述，并包含了 2020 年至 2031 年的历史数据和预测数据。透过定量和定性分析，我们帮助读者制定业务/成长策略，评估市场竞争格局，分析自身在当前市场中的地位，并就冠状动脉绕道手术术 (CABG) 做出明智的商业决策。

市场区隔

公司

  • Medtronic
  • Getinge Group
  • LivaNova
  • Terumo
  • Boston Scientific
  • Stryker
  • Edwards Lifesciences
  • Genesee Biomedical
  • Karl Storz GmbH

按类型分類的细分市场

  • 大隐静脉移植
  • 内乳动脉移植
  • 其他的

应用领域

  • 传统冠状动脉绕道手术
  • 非传统冠状动脉绕道手术

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Coronary Artery Bypass Grafts (CABG) was estimated to be worth US$ 142 million in 2024 and is forecast to a readjusted size of US$ 202 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Coronary artery bypass grafting (CABG) is a surgical intervention to restore myocardial blood supply by creating bypass conduits-using autologous or alternative vascular grafts-around narrowed or occluded coronary arteries to preserve cardiac muscle, relieve ischemic symptoms, and reduce the risk of adverse cardiac events. As a standard of care for multivessel and complex coronary disease, CABG spans from conventional open-chest on-pump procedures to refined, less invasive techniques and supporting adjuncts. The perioperative ecosystem-graft preservation, intraoperative perfusion management, hemostasis, consumables, and postoperative rehabilitation-forms an integrated market that includes devices, disposables, pharmacologic adjuncts, and service offerings.

The sustained public-health emphasis on cardiovascular disease burden provides an enduring demand base for CABG where durable outcomes and long-term quality of life matter. Innovations in graft preservation, intraoperative blood management and alternative conduit materials, together with commercialization by listed and R&D companies, are expanding addressable product categories and creating premium commercialization opportunities for firms that can pair clinical evidence with scalable manufacturing.

Major restraints include rigid regulatory requirements, the need for long-term clinical evidence, and stringent quality controls. Novel devices and graft materials typically require extended clinical programs and regulatory interactions before adoption into standard surgical pathways; post-market safety or quality issues can materially impact compliance costs and brand trust. Supply-chain robustness, sterile manufacturing capability, and hospital budget dynamics also present tangible commercialization risks.

This report aims to provide a comprehensive presentation of the global market for Coronary Artery Bypass Grafts (CABG), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Coronary Artery Bypass Grafts (CABG) by region & country, by Type, and by Application.

The Coronary Artery Bypass Grafts (CABG) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Artery Bypass Grafts (CABG).

Market Segmentation

By Company

  • Medtronic
  • Getinge Group
  • LivaNova
  • Terumo
  • Boston Scientific
  • Stryker
  • Edwards Lifesciences
  • Genesee Biomedical
  • Karl Storz GmbH

Segment by Type

  • Saphenous Vein Grafts
  • Internal Thoracic Artery Grafts
  • Other

Segment by Application

  • Traditional CABG
  • Nontraditional CABG

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Coronary Artery Bypass Grafts (CABG) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Coronary Artery Bypass Grafts (CABG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Coronary Artery Bypass Grafts (CABG) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Coronary Artery Bypass Grafts (CABG) Product Introduction
  • 1.2 Global Coronary Artery Bypass Grafts (CABG) Market Size Forecast (2020-2031)
  • 1.3 Coronary Artery Bypass Grafts (CABG) Market Trends & Drivers
    • 1.3.1 Coronary Artery Bypass Grafts (CABG) Industry Trends
    • 1.3.2 Coronary Artery Bypass Grafts (CABG) Market Drivers & Opportunity
    • 1.3.3 Coronary Artery Bypass Grafts (CABG) Market Challenges
    • 1.3.4 Coronary Artery Bypass Grafts (CABG) Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Coronary Artery Bypass Grafts (CABG) Players Revenue Ranking (2024)
  • 2.2 Global Coronary Artery Bypass Grafts (CABG) Revenue by Company (2020-2025)
  • 2.3 Key Companies Coronary Artery Bypass Grafts (CABG) Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Coronary Artery Bypass Grafts (CABG) Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Coronary Artery Bypass Grafts (CABG)
  • 2.6 Coronary Artery Bypass Grafts (CABG) Market Competitive Analysis
    • 2.6.1 Coronary Artery Bypass Grafts (CABG) Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Coronary Artery Bypass Grafts (CABG) Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Artery Bypass Grafts (CABG) as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Saphenous Vein Grafts
    • 3.1.2 Internal Thoracic Artery Grafts
    • 3.1.3 Other
  • 3.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type
    • 3.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value, by Type (2020-2031)
    • 3.2.3 Global Coronary Artery Bypass Grafts (CABG) Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Traditional CABG
    • 4.1.2 Nontraditional CABG
  • 4.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application
    • 4.2.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value, by Application (2020-2031)
    • 4.2.3 Global Coronary Artery Bypass Grafts (CABG) Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region
    • 5.1.1 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2020-2025)
    • 5.1.3 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2026-2031)
    • 5.1.4 Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.2.2 North America Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.3.2 Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.5.2 South America Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.3.2 United States Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.4.2 Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.5.2 China Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.6.2 Japan Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.7.2 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Coronary Artery Bypass Grafts (CABG) Sales Value, 2020-2031
    • 6.9.2 India Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Coronary Artery Bypass Grafts (CABG) Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Medtronic
    • 7.1.1 Medtronic Profile
    • 7.1.2 Medtronic Main Business
    • 7.1.3 Medtronic Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.1.4 Medtronic Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Medtronic Recent Developments
  • 7.2 Getinge Group
    • 7.2.1 Getinge Group Profile
    • 7.2.2 Getinge Group Main Business
    • 7.2.3 Getinge Group Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.2.4 Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Getinge Group Recent Developments
  • 7.3 LivaNova
    • 7.3.1 LivaNova Profile
    • 7.3.2 LivaNova Main Business
    • 7.3.3 LivaNova Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.3.4 LivaNova Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.3.5 LivaNova Recent Developments
  • 7.4 Terumo
    • 7.4.1 Terumo Profile
    • 7.4.2 Terumo Main Business
    • 7.4.3 Terumo Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.4.4 Terumo Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Terumo Recent Developments
  • 7.5 Boston Scientific
    • 7.5.1 Boston Scientific Profile
    • 7.5.2 Boston Scientific Main Business
    • 7.5.3 Boston Scientific Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.5.4 Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Boston Scientific Recent Developments
  • 7.6 Stryker
    • 7.6.1 Stryker Profile
    • 7.6.2 Stryker Main Business
    • 7.6.3 Stryker Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.6.4 Stryker Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Stryker Recent Developments
  • 7.7 Edwards Lifesciences
    • 7.7.1 Edwards Lifesciences Profile
    • 7.7.2 Edwards Lifesciences Main Business
    • 7.7.3 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.7.4 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Edwards Lifesciences Recent Developments
  • 7.8 Genesee Biomedical
    • 7.8.1 Genesee Biomedical Profile
    • 7.8.2 Genesee Biomedical Main Business
    • 7.8.3 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.8.4 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Genesee Biomedical Recent Developments
  • 7.9 Karl Storz GmbH
    • 7.9.1 Karl Storz GmbH Profile
    • 7.9.2 Karl Storz GmbH Main Business
    • 7.9.3 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
    • 7.9.4 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Karl Storz GmbH Recent Developments

8 Industry Chain Analysis

  • 8.1 Coronary Artery Bypass Grafts (CABG) Industrial Chain
  • 8.2 Coronary Artery Bypass Grafts (CABG) Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Coronary Artery Bypass Grafts (CABG) Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Coronary Artery Bypass Grafts (CABG) Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Coronary Artery Bypass Grafts (CABG) Market Trends
  • Table 2. Coronary Artery Bypass Grafts (CABG) Market Drivers & Opportunity
  • Table 3. Coronary Artery Bypass Grafts (CABG) Market Challenges
  • Table 4. Coronary Artery Bypass Grafts (CABG) Market Restraints
  • Table 5. Global Coronary Artery Bypass Grafts (CABG) Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Coronary Artery Bypass Grafts (CABG) Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Coronary Artery Bypass Grafts (CABG) Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Coronary Artery Bypass Grafts (CABG)
  • Table 10. Global Coronary Artery Bypass Grafts (CABG) Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Artery Bypass Grafts (CABG) as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Coronary Artery Bypass Grafts (CABG) Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Coronary Artery Bypass Grafts (CABG) Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Coronary Artery Bypass Grafts (CABG) Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Coronary Artery Bypass Grafts (CABG) Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Medtronic Basic Information List
  • Table 32. Medtronic Description and Business Overview
  • Table 33. Medtronic Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Medtronic (2020-2025)
  • Table 35. Medtronic Recent Developments
  • Table 36. Getinge Group Basic Information List
  • Table 37. Getinge Group Description and Business Overview
  • Table 38. Getinge Group Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Getinge Group (2020-2025)
  • Table 40. Getinge Group Recent Developments
  • Table 41. LivaNova Basic Information List
  • Table 42. LivaNova Description and Business Overview
  • Table 43. LivaNova Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of LivaNova (2020-2025)
  • Table 45. LivaNova Recent Developments
  • Table 46. Terumo Basic Information List
  • Table 47. Terumo Description and Business Overview
  • Table 48. Terumo Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Terumo (2020-2025)
  • Table 50. Terumo Recent Developments
  • Table 51. Boston Scientific Basic Information List
  • Table 52. Boston Scientific Description and Business Overview
  • Table 53. Boston Scientific Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Boston Scientific (2020-2025)
  • Table 55. Boston Scientific Recent Developments
  • Table 56. Stryker Basic Information List
  • Table 57. Stryker Description and Business Overview
  • Table 58. Stryker Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Stryker (2020-2025)
  • Table 60. Stryker Recent Developments
  • Table 61. Edwards Lifesciences Basic Information List
  • Table 62. Edwards Lifesciences Description and Business Overview
  • Table 63. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Edwards Lifesciences (2020-2025)
  • Table 65. Edwards Lifesciences Recent Developments
  • Table 66. Genesee Biomedical Basic Information List
  • Table 67. Genesee Biomedical Description and Business Overview
  • Table 68. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Genesee Biomedical (2020-2025)
  • Table 70. Genesee Biomedical Recent Developments
  • Table 71. Karl Storz GmbH Basic Information List
  • Table 72. Karl Storz GmbH Description and Business Overview
  • Table 73. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Coronary Artery Bypass Grafts (CABG) Business of Karl Storz GmbH (2020-2025)
  • Table 75. Karl Storz GmbH Recent Developments
  • Table 76. Key Raw Materials Lists
  • Table 77. Raw Materials Key Suppliers Lists
  • Table 78. Coronary Artery Bypass Grafts (CABG) Downstream Customers
  • Table 79. Coronary Artery Bypass Grafts (CABG) Distributors List
  • Table 80. Research Programs/Design for This Report
  • Table 81. Key Data Information from Secondary Sources
  • Table 82. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Coronary Artery Bypass Grafts (CABG) Product Picture
  • Figure 2. Global Coronary Artery Bypass Grafts (CABG) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Coronary Artery Bypass Grafts (CABG) Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Coronary Artery Bypass Grafts (CABG) Report Years Considered
  • Figure 5. Global Coronary Artery Bypass Grafts (CABG) Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Coronary Artery Bypass Grafts (CABG) Revenue in 2024
  • Figure 7. Coronary Artery Bypass Grafts (CABG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Saphenous Vein Grafts Picture
  • Figure 9. Internal Thoracic Artery Grafts Picture
  • Figure 10. Other Picture
  • Figure 11. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Coronary Artery Bypass Grafts (CABG) Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Traditional CABG
  • Figure 14. Product Picture of Nontraditional CABG
  • Figure 15. Global Coronary Artery Bypass Grafts (CABG) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Coronary Artery Bypass Grafts (CABG) Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Coronary Artery Bypass Grafts (CABG) Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Coronary Artery Bypass Grafts (CABG) Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Coronary Artery Bypass Grafts (CABG) Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Coronary Artery Bypass Grafts (CABG) Sales Value (%), (2020-2031)
  • Figure 28. United States Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Coronary Artery Bypass Grafts (CABG) Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Coronary Artery Bypass Grafts (CABG) Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Coronary Artery Bypass Grafts (CABG) Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Coronary Artery Bypass Grafts (CABG) Industrial Chain
  • Figure 50. Coronary Artery Bypass Grafts (CABG) Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed